Clotilde Billottet

1.1k total citations
21 papers, 823 citations indexed

About

Clotilde Billottet is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Clotilde Billottet has authored 21 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Immunology. Recurrent topics in Clotilde Billottet's work include Chemokine receptors and signaling (5 papers), Immunotherapy and Immune Responses (5 papers) and Fibroblast Growth Factor Research (4 papers). Clotilde Billottet is often cited by papers focused on Chemokine receptors and signaling (5 papers), Immunotherapy and Immune Responses (5 papers) and Fibroblast Growth Factor Research (4 papers). Clotilde Billottet collaborates with scholars based in France, United Kingdom and Switzerland. Clotilde Billottet's co-authors include Andréas Bikfalvi, Cathy Quemener, Jacqueline Jouanneau, Asim Khwaja, Elisabeth Génot, Jean Paul Thiery, Frédéric Saltel, Rosemary E. Gale, Christian Rommel and Victoria Grandage and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Clotilde Billottet

21 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clotilde Billottet France 14 408 268 193 159 127 21 823
Andreas Enns Germany 9 506 1.2× 289 1.1× 137 0.7× 143 0.9× 129 1.0× 9 889
Maya Zigler United States 17 565 1.4× 300 1.1× 273 1.4× 93 0.6× 184 1.4× 23 961
Anja Weigmann Germany 7 450 1.1× 278 1.0× 99 0.5× 137 0.9× 149 1.2× 9 785
Helena Kiefel Germany 17 605 1.5× 341 1.3× 253 1.3× 134 0.8× 257 2.0× 23 1.2k
Javier Redondo-Muñóz Spain 16 576 1.4× 251 0.9× 225 1.2× 163 1.0× 209 1.6× 27 990
Paola Marighetti Italy 15 353 0.9× 341 1.3× 96 0.5× 207 1.3× 177 1.4× 17 877
Cécile Rouleau United States 16 444 1.1× 241 0.9× 93 0.5× 80 0.5× 129 1.0× 26 732
Gabriel J. Villares United States 18 666 1.6× 330 1.2× 241 1.2× 97 0.6× 271 2.1× 19 1.2k
Elínborg Ostermann Austria 10 403 1.0× 318 1.2× 151 0.8× 117 0.7× 97 0.8× 13 766
Elizabeth M. Morse United States 11 416 1.0× 525 2.0× 602 3.1× 167 1.1× 66 0.5× 14 1.2k

Countries citing papers authored by Clotilde Billottet

Since Specialization
Citations

This map shows the geographic impact of Clotilde Billottet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clotilde Billottet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clotilde Billottet more than expected).

Fields of papers citing papers by Clotilde Billottet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clotilde Billottet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clotilde Billottet. The network helps show where Clotilde Billottet may publish in the future.

Co-authorship network of co-authors of Clotilde Billottet

This figure shows the co-authorship network connecting the top 25 collaborators of Clotilde Billottet. A scholar is included among the top collaborators of Clotilde Billottet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clotilde Billottet. Clotilde Billottet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raymond, Anne‐Aurélie, Jean‐William Dupuy, Mélina Petrel, et al.. (2024). Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma. eLife. 13. 3 indexed citations
2.
Billottet, Clotilde, et al.. (2024). Specific features of ß-catenin-mutated hepatocellular carcinomas. British Journal of Cancer. 131(12). 1871–1880. 4 indexed citations
3.
Raymond, Anne‐Aurélie, Jean‐William Dupuy, Mélina Petrel, et al.. (2024). Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma. eLife. 13. 4 indexed citations
4.
Lorusso, Girieca, François Kuonen, Nicola Vannini, et al.. (2022). Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation. Science Translational Medicine. 14(661). eaax8933–eaax8933. 28 indexed citations
5.
Billottet, Clotilde, Christophe Schneider, Nicolas Etique, et al.. (2021). LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis. Biomedicines. 9(10). 1430–1430. 13 indexed citations
6.
Bikfalvi, Andréas & Clotilde Billottet. (2020). The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment. American Journal of Physiology-Cell Physiology. 318(3). C542–C554. 72 indexed citations
7.
Boyé, Kevin, Isabel D. Alves, Yaping Chen, et al.. (2017). The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors. Nature Communications. 8(1). 1571–1571. 44 indexed citations
8.
Boyé, Kevin, et al.. (2017). Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR). Scientific Reports. 7(1). 10703–10703. 20 indexed citations
9.
Chen, Yaping, Kevin Boyé, Chun‐Wei Lin, et al.. (2017). Oligomerization State of CXCL4 Chemokines Regulates G Protein-Coupled Receptor Activation. ACS Chemical Biology. 12(11). 2767–2778. 10 indexed citations
11.
Billottet, Clotilde, Cathy Quemener, & Andréas Bikfalvi. (2013). CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1836(2). 287–295. 125 indexed citations
12.
Juin, Amélie, Clotilde Billottet, Violaine Moreau, et al.. (2011). Physiological type I collagen organization induces the formation of a novel class of linear invadosomes. Molecular Biology of the Cell. 23(2). 297–309. 79 indexed citations
14.
Billottet, Clotilde, Marianne Tuefferd, David Gentien, et al.. (2008). Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells. Journal of Cellular Biochemistry. 104(3). 826–839. 45 indexed citations
15.
Billottet, Clotilde, Florence Tatin, Christine Varon, et al.. (2008). Regulatory signals for endothelial podosome formation. European Journal of Cell Biology. 87(8-9). 543–554. 21 indexed citations
16.
Billottet, Clotilde & Jacqueline Jouanneau. (2008). [Tumor-stroma interactions].. PubMed. 95(1). 51–6. 10 indexed citations
17.
Billottet, Clotilde, Victoria Grandage, Rosemary E. Gale, et al.. (2006). A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene. 25(50). 6648–6659. 125 indexed citations
18.
Billottet, Clotilde, Nadia Elkhatib, Jean Paul Thiery, & Jacqueline Jouanneau. (2004). Targets of Fibroblast Growth Factor 1 (FGF-1) and FGF-2 Signaling Involved in the Invasive and Tumorigenic Behavior of Carcinoma Cells. Molecular Biology of the Cell. 15(10). 4725–4734. 42 indexed citations
19.
Malavaud, Bernard, Sylvie Sordello, Catherine Mazerolles, et al.. (2004). Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells. Oncogene. 23(40). 6769–6778. 3 indexed citations
20.
Billottet, Clotilde, Bassam Janji, Jean Paul Thiery, & Jacqueline Jouanneau. (2002). Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene. 21(53). 8128–8139. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026